Aflibercept in Diabetic Macular Edema Refractory to Previous Bevacizumab: Outcomes and Predictors of Success
AuthID
P-00N-5YQ
P-00N-5YQ
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service